197 related articles for article (PubMed ID: 23970800)
1. Pretreatment with TCDD exacerbates liver injury from Concanavalin A: critical role for NK cells.
Fullerton AM; Roth RA; Ganey PE
Toxicol Sci; 2013 Nov; 136(1):72-85. PubMed ID: 23970800
[TBL] [Abstract][Full Text] [Related]
2. 2,3,7,8-TCDD enhances the sensitivity of mice to concanavalin A immune-mediated liver injury.
Fullerton AM; Roth RA; Ganey PE
Toxicol Appl Pharmacol; 2013 Jan; 266(2):317-27. PubMed ID: 23164664
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 5 signaling restrains T-cell/natural killer T-cell activation and protects against concanavalin A-induced hepatic injury.
Wang L; Zhang W; Ge CH; Yin RH; Xiao Y; Zhan YQ; Yu M; Li CY; Ge ZQ; Yang XM
Hepatology; 2017 Jun; 65(6):2059-2073. PubMed ID: 28273362
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial-targeted ubiquinone alleviates concanavalin A-induced hepatitis via immune modulation.
Desta YT; Wu M; Bai L; Wu X; Xiong M; Weng X
Int Immunopharmacol; 2020 Jul; 84():106518. PubMed ID: 32380408
[TBL] [Abstract][Full Text] [Related]
5. NKG2A inhibits invariant NKT cell activation in hepatic injury.
Kawamura T; Takeda K; Kaneda H; Matsumoto H; Hayakawa Y; Raulet DH; Ikarashi Y; Kronenberg M; Yagita H; Kinoshita K; Abo T; Okumura K; Smyth MJ
J Immunol; 2009 Jan; 182(1):250-8. PubMed ID: 19109156
[TBL] [Abstract][Full Text] [Related]
6. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice.
Toyabe S; Seki S; Iiai T; Takeda K; Shirai K; Watanabe H; Hiraide H; Uchiyama M; Abo T
J Immunol; 1997 Aug; 159(3):1537-42. PubMed ID: 9233653
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of concanavalin A-induced hepatic injury of mice by bacterial lipopolysaccharide via the induction of IL-6 and the subsequent reduction of IL-4: the cytokine milieu of concanavalin A hepatitis.
Nishikage T; Seki S; Toyabe S; Abo T; Kagata Y; Iwai T; Hiraide H
J Hepatol; 1999 Jul; 31(1):18-26. PubMed ID: 10424279
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-15 prevents concanavalin A-induced liver injury in mice via NKT cell-dependent mechanism.
Li B; Sun R; Wei H; Gao B; Tian Z
Hepatology; 2006 Jun; 43(6):1211-9. PubMed ID: 16729307
[TBL] [Abstract][Full Text] [Related]
9. CD49a promotes T-cell-mediated hepatitis by driving T helper 1 cytokine and interleukin-17 production.
Chen Y; Peng H; Chen Y; Wei H; Sun R; Tian Z
Immunology; 2014 Mar; 141(3):388-400. PubMed ID: 24164540
[TBL] [Abstract][Full Text] [Related]
10. Consequences of TCDD treatment on intra-hepatic lymphocytes during liver regeneration.
Horras CJ; Lamb CL; King AL; Hanley JR; Mitchell KA
J Immunotoxicol; 2012; 9(4):359-67. PubMed ID: 22530936
[TBL] [Abstract][Full Text] [Related]
11. Blockade of IL-33 ameliorates Con A-induced hepatic injury by reducing NKT cell activation and IFN-γ production in mice.
Chen J; Duan L; Xiong A; Zhang H; Zheng F; Tan Z; Gong F; Fang M
J Mol Med (Berl); 2012 Dec; 90(12):1505-15. PubMed ID: 22983503
[TBL] [Abstract][Full Text] [Related]
12. CD1d-restricted natural killer T cells contribute to hepatic inflammation and fibrogenesis in mice.
Ishikawa S; Ikejima K; Yamagata H; Aoyama T; Kon K; Arai K; Takeda K; Watanabe S
J Hepatol; 2011 Jun; 54(6):1195-204. PubMed ID: 21145835
[TBL] [Abstract][Full Text] [Related]
13. Diammonium Glycyrrhizinate Mitigates Liver Injury Via Inhibiting Proliferation Of NKT Cells And Promoting Proliferation Of Tregs.
Gao M; Li X; He L; Yang J; Ye X; Xiao F; Wei H
Drug Des Devel Ther; 2019; 13():3579-3589. PubMed ID: 31802846
[TBL] [Abstract][Full Text] [Related]
14. Lack of macrophage migration inhibitory factor protects mice against concanavalin A-induced liver injury.
Nakajima H; Takagi H; Horiguchi N; Toyoda M; Kanda D; Otsuka T; Emoto Y; Emoto M; Mori M
Liver Int; 2006 Apr; 26(3):346-51. PubMed ID: 16584398
[TBL] [Abstract][Full Text] [Related]
15. Preactivation of NKT cells with alpha-GalCer protects against hepatic ischemia-reperfusion injury in mouse by a mechanism involving IL-13 and adenosine A2A receptor.
Cao Z; Yuan Y; Jeyabalan G; Du Q; Tsung A; Geller DA; Billiar TR
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G249-58. PubMed ID: 19556359
[TBL] [Abstract][Full Text] [Related]
16. Protectin D1 reduces concanavalin A-induced liver injury by inhibiting NF-κB-mediated CX3CL1/CX3CR1 axis and NLR family, pyrin domain containing 3 inflammasome activation.
Ren J; Meng S; Yan B; Yu J; Liu J
Mol Med Rep; 2016 Apr; 13(4):3627-38. PubMed ID: 26955849
[TBL] [Abstract][Full Text] [Related]
17. Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis.
Beldi G; Wu Y; Banz Y; Nowak M; Miller L; Enjyoji K; Haschemi A; Yegutkin GG; Candinas D; Exley M; Robson SC
Hepatology; 2008 Sep; 48(3):841-52. PubMed ID: 18752325
[TBL] [Abstract][Full Text] [Related]
18. Distinct contributions of CD4+ T cell subsets in hepatic ischemia/reperfusion injury.
Kuboki S; Sakai N; Tschöp J; Edwards MJ; Lentsch AB; Caldwell CC
Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1054-9. PubMed ID: 19264952
[TBL] [Abstract][Full Text] [Related]
19. Superoxide produced by Kupffer cells is an essential effector in concanavalin A-induced hepatitis in mice.
Nakashima H; Kinoshita M; Nakashima M; Habu Y; Shono S; Uchida T; Shinomiya N; Seki S
Hepatology; 2008 Dec; 48(6):1979-88. PubMed ID: 18942689
[TBL] [Abstract][Full Text] [Related]
20. Metformin aggravates immune-mediated liver injury in mice.
Volarevic V; Misirkic M; Vucicevic L; Paunovic V; Simovic Markovic B; Stojanovic M; Milovanovic M; Jakovljevic V; Micic D; Arsenijevic N; Trajkovic V; Lukic ML
Arch Toxicol; 2015 Mar; 89(3):437-50. PubMed ID: 24770553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
